Acute Profound Thrombocytopenia after Using Abciximab for No-Reflow during Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction

Glycoprotein IIb/IIIa antagonists are well established for their effectiveness in improving clinical outcomes in acute coronary syndrome patients undergoing percutaneous coronary intervention. Acute profound thrombocytopenia is a rare complication of abciximab. We present a case which was managed su...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Soonyoung, Lee, Jooyoung, Lee, Sang Yeub, Bae, Jang-Whan, Hwang, Kyung-Kuk, Kim, Dong-Woon, Cho, Myeong-Chan, Kim, Sang Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Cardiology 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3772301/
https://www.ncbi.nlm.nih.gov/pubmed/24044015
http://dx.doi.org/10.4070/kcj.2013.43.8.557

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3772301/
https://www.ncbi.nlm.nih.gov/pubmed/24044015
http://dx.doi.org/10.4070/kcj.2013.43.8.557

Ejemplares similares